1
|
Lee HY, Lee EH, Yi J, Ji KY, Kim SM, Choi HR, Yee SM, Kang HS, Kim EM. TREM2 promotes natural killer cell development in CD3 -CD122 +NK1.1 + pNK cells. BMC Immunol 2021; 22:30. [PMID: 33980160 PMCID: PMC8114489 DOI: 10.1186/s12865-021-00420-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2020] [Accepted: 04/06/2021] [Indexed: 01/16/2023] Open
Abstract
Background Triggering receptor expressed on myeloid cells 2 (TREM2) signaling is considered to regulate anti-inflammatory responses in macrophages, dendritic cell maturation, osteoclast development, induction of obesity, and Alzheimer’s disease pathogenesis. However, little is known regarding the effect of TREM2 on natural killer (NK) cells. Results Here, we demonstrated for the first time that CD3−CD122+NK1.1+ precursor NK (pNK) cells expressed TREM2 and their population increased in TREM2-overexpressing transgenic (TREM2-TG) mice compared with that in female C57BL/6 J wild type (WT) mice. Both NK cell-activating receptors and NK cell-associated genes were expressed at higher levels in various tissues of TREM2-TG mice than in WT mice. In addition, bone marrow-derived hematopoietic stem cells (HSCs) of TREM2-TG mice (TG-HSCs) successfully differentiated into NK cells in vitro, with a higher yield from TG-HSCs than from WT-HSCs. In contrast, TREM2 signaling inhibition by TREM2-Ig or a phosphatidylinositol 3-kinase (PI3K) inhibitor affected the expression of the NK cell receptor repertoire and decreased the expression levels of NK cell-associated genes, resulting in significant impairment of NK cell differentiation. Moreover, in melanoma-bearing WT mice, injection of bone marrow cells from TREM2-TG mice exerted greater antitumor effects than that with cells from WT control mice. Conclusions Collectively, our data clearly showed that TREM2 promoted NK cell development and tumor regression, suggesting TREM2 as a new candidate for cancer immunotherapy. Supplementary Information The online version contains supplementary material available at 10.1186/s12865-021-00420-0.
Collapse
Affiliation(s)
- Hwa-Youn Lee
- Chemicals Registration & Evaluation Team, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon, 22689, Korea
| | - Eun-Hee Lee
- Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, 80 Cheombok-ro, Dong-gu, Daegu, 41061, Korea
| | - Jawoon Yi
- School of Biological Sciences and Technology, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, 61186, Republic of Korea
| | - Kon-Young Ji
- Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 461-24 Jeonmin-dong, Yuseong-gu, Daejeon, 34054, Korea
| | - Su-Man Kim
- School of Biological Sciences and Technology, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, 61186, Republic of Korea
| | - Ha-Rim Choi
- Department of Nursing, Nambu University, 23 Chumdan Jungang-ro, Gwangsan-gu, Gwangju, 62271, Korea
| | - Su-Min Yee
- School of Biological Sciences and Technology, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, 61186, Republic of Korea
| | - Hyung-Sik Kang
- School of Biological Sciences and Technology, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, 61186, Republic of Korea.
| | - Eun-Mi Kim
- Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.
| |
Collapse
|
2
|
Kim EM, Lee EH, Lee HY, Choi HR, Ji KY, Kim SM, Kim KD, Kang HS. Axl signaling induces development of natural killer cells in vitro and in vivo. PROTOPLASMA 2017; 254:1091-1101. [PMID: 27549806 DOI: 10.1007/s00709-016-1016-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/28/2016] [Accepted: 08/07/2016] [Indexed: 06/06/2023]
Abstract
Natural killer (NK) cells have been well known to play a critical role in innate immunity, but they are also capable of regulating adaptive immunity through the induction of T cell-mediated memory response and B cell-mediated autoimmune response. NK cells are differentiated from hematopoietic stem cells (HSCs) in the bone marrow (BM), and a series of surface molecules are expressed on NK cells in a differentiation stage-specific manner. Axl receptor tyrosine kinase is originally identified as homeostatic regulators for antigen-presenting cells, and its ligand, growth-arrest-specific gene 6 (Gas6), has been reported to promote cell survival, proliferation, and migration, but their regulatory role in the development and effector function of NK cells is not yet fully understood. In this study, to investigate whether Axl is required for the regulation of NK cell development, the expression of mature NK (mNK) cell-specific receptors and NK cell-associated genes was analyzed in the differentiated HSCs-derived NK cells in vitro and the NK cells harvested from Axl-/- mice. We found that agonistic anti-Axl antibody or recombinant Gas6 specifically upregulated the expression of mNK cell-specific receptors, such as LY49A, Ly49G2, Ly49C/F/I, NKG2A/C/E (1.5- to 3.5-fold increase), and NK cell-associated genes, such as IL-2Rβ (2.3- or 2.4-fold increase), Perforin (4.1- or 2.1-fold increase), IL-15Rα (2.14- or 2.04-fold increase), and IFN-γ (3.3- or 2.8-fold increase) compared to each isotype control, whereas it was abrogated by treatment of Axl-Ig. Anti-Axl antibody or rGas6 also induced a 2.5- or 1.9-fold increase in the proliferation of developing NK cells compared to each control, respectively. mNK cell populations expressing mNK cell-specific receptors were reduced about twofold in NK cells differentiated from HSCs of Axl-/- mice compared with those of wild-type mice. Furthermore, the triggering of Axl signaling by agonistic anti-Axl antibody promoted the cytolytic activity (1.5- to 1.9-fold increase) against target tumor cells. In B16F10 melanoma-bearing mice, the number of metastatic colonies was decreased by 83 % by the administration of mNK cells treated with anti-Axl antibody compared to control Ig. These data suggest that Axl plays an essential role in the regulation of NK cell development as well as NK effector function.
Collapse
Affiliation(s)
- Eun-Mi Kim
- Internal Medicine, University of Iowa and VA Medical Center, Iowa City, IA, 52246, USA
| | - Eun-Hee Lee
- Advanced Radiation Technology Institute (ARTI), Korea Atomic Energy Institute (KAERI), 29 Geumgu-gil, Jeongeup-si, Jeollabuk-do, 580-185, South Korea
| | - Hwa-Yeon Lee
- Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Cheombok-ro 80, Dong-gu, Daegu, 41061, South Korea
| | - Ha-Rim Choi
- Department of Nursing, Nambu University, 23 Chumdan Jungang-ro, Gwangsan-gu, Gwangju, 506-706, South Korea
| | - Kon-Young Ji
- School of Biological Sciences and Technology, Chonnam National University, 300 Yongbong-dong, Bukgu, Gwangju, 500-757, Republic of Korea
| | - Su-Man Kim
- School of Biological Sciences and Technology, Chonnam National University, 300 Yongbong-dong, Bukgu, Gwangju, 500-757, Republic of Korea
| | - Kwang Dong Kim
- Division of Applied Life Science, PMBBRC, Gyeongsang National University, Jinju, 660-701, South Korea
| | - Hyung-Sik Kang
- School of Biological Sciences and Technology, Chonnam National University, 300 Yongbong-dong, Bukgu, Gwangju, 500-757, Republic of Korea.
| |
Collapse
|
3
|
Kota H, Chamberlain RS. Immunonutrition Is Associated With a Decreased Incidence of Graft-Versus-Host Disease in Bone Marrow Transplant Recipients: A Meta-Analysis. JPEN J Parenter Enteral Nutr 2016; 41:1286-1292. [DOI: 10.1177/0148607116663278] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Harshitha Kota
- Saint George’s University School of Medicine, Grenada, West Indies
| | - Ronald S. Chamberlain
- Saint George’s University School of Medicine, Grenada, West Indies
- New Jersey Medical School, Rutgers University, Newark, New Jersey, USA
- Department of Surgery, Saint Barnabas Medical Center, Livingston, New Jersey, USA
| |
Collapse
|
4
|
Becherucci V, Allegro E, Brugnolo F, Piccini L, Gori V, Bisin S, Bindi B, Ceccantini R, Pavan P, Cunial V, Gentile F, Ermini S, Bambi F. Extracorporeal photopheresis as an immunomodulatory agent: Haematocrit-dependent effects on natural killer cells. J Clin Apher 2016; 32:257-265. [PMID: 27476149 DOI: 10.1002/jca.21490] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2015] [Revised: 06/18/2016] [Accepted: 07/10/2016] [Indexed: 12/22/2022]
Abstract
The GvHD is a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Extracorporeal photopheresis (ECP) represents an alternative therapeutic strategy to immunosuppressive therapy. Although ECP is used since 1990s, the mechanism of action has not yet been completely clarified. We analyzed cells collected from 20 ECP procedures of 4 patients affected by chronic GvHD and, for comparison, Peripheral Blood Mononuclear Cells (PBMCs) of 10 healthy donors undergoing from same type of photochemiotherapy, evaluating by flow cytometry, the effects before and after photoactivation with 8-MOP. The analysis showed a significant increase in cell death after ECP in particular in CD4 T lymphocytes as described in literature correlated with haematocrit value. Most interesting data emerge from the analysis of cytotoxic activity of NK cells, using flow cytometry analysis of surface expression of CD107a in the presence of target cells (K562). In all analyzed samples it was possible to document a statistically significant reduction of the cytotoxic activity of NK cells after photoactivation. The decrease of the cytotoxic activity was related to hematocrit value of leukoapheresis: in fact, lower HCT values were associated with a more marked reduction of cytotoxic activity. The study confirms literature data about the increase of cellular mortality induce by ECP. Furthermore, for the first time it is demonstrated that the ECP exerts a marked and significant inhibitory effect on the cytotoxic activity of NK cells. Our study suggests that lower values of hematocrit are associated with better treatment outcome.
Collapse
Affiliation(s)
- V Becherucci
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - E Allegro
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - F Brugnolo
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - L Piccini
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - V Gori
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - S Bisin
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - B Bindi
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - R Ceccantini
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - P Pavan
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - V Cunial
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - F Gentile
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - S Ermini
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| | - F Bambi
- Department of Oncohematology, Cell Therapy Laboratory, Azienda Ospedaliero Universitaria Meyer, AOU Meyer, Florence, Italy
| |
Collapse
|
5
|
Kang HS, Kim EM, Lee S, Yoon SR, Kawamura T, Lee YC, Kim S, Myung PK, Wang SM, Choi I. Stage-dependent gene expression profiles during natural killer cell development. Genomics 2005; 86:551-65. [PMID: 16054799 DOI: 10.1016/j.ygeno.2005.06.010] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2004] [Revised: 05/31/2005] [Accepted: 06/11/2005] [Indexed: 11/17/2022]
Abstract
Natural killer (NK) cells develop from hematopoietic stem cells (HSCs) in the bone marrow. To understand the molecular regulation of NK cell development, serial analysis of gene expression (SAGE) was applied to HSCs, NK precursor (pNK) cells, and mature NK cells (mNK) cultured without or with OP9 stromal cells. From 170,464 total individual tags from four SAGE libraries, 35,385 unique genes were identified. A set of genes was expressed in a stage-specific manner: 15 genes in HSCs, 30 genes in pNK cells, and 27 genes in mNK cells. Among them, lipoprotein lipase induced NK cell maturation and cytotoxic activity. Identification of genome-wide profiles of gene expression in different stages of NK cell development affords us a fundamental basis for defining the molecular network during NK cell development.
Collapse
Affiliation(s)
- Hyung-Sik Kang
- Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757, Republic of Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Maeda Y, Reddy P, Lowler KP, Liu C, Bishop DK, Ferrara JLM. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood 2005; 106:749-55. [PMID: 15797996 PMCID: PMC1895173 DOI: 10.1182/blood-2004-10-4087] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2004] [Accepted: 12/03/2004] [Indexed: 11/20/2022] Open
Abstract
Gammadelta T cells localize to target tissues of graft-versus-host disease (GVHD) and therefore we investigated the role of host gammadelta T cells in the pathogenesis of acute GVHD in several well-characterized allogeneic bone marrow transplantation (BMT) models. Depletion of host gammadelta T cells in wild-type (wt) B6 recipients by administration of anti-T-cell receptor (TCR) gammadelta monoclonal antibody reduced GVHD, and gammadelta T-cell-deficient (gammadelta-/-) BM transplant recipients experienced markedly improved survival compared with normal controls (63% vs 10%, P < .001). gammadelta T cells were responsible for this difference because reconstitution of gammadelta-/- recipients with gammadelta T cells restored GVHD mortality. gammadelta-/- recipients showed decreased serum levels of tumor necrosis factor alpha (TNF-alpha), less GVHD histopathologic damage, and reduced donor T-cell expansion. Mechanistic analysis of this phenomenon demonstrated that dendritic cells (DCs) from gammadelta-/- recipients exhibited less allostimulatory capacity compared to wt DCs after irradiation. Normal DCs derived from BM caused greater allogeneic T-cell proliferation when cocultured with gammadelta T cells than DCs cocultured with medium alone. This enhancement did not depend on interferon gamma (IFN-gamma), TNF-alpha, or CD40 ligand but did depend on cell-to-cell contact. These data demonstrated that the host gammadelta T cells exacerbate GVHD by enhancing the allostimulatory capacity of host antigen-presenting cells.
Collapse
MESH Headings
- Acute Disease
- Adoptive Transfer
- Animals
- Bone Marrow Transplantation/adverse effects
- Bone Marrow Transplantation/immunology
- Bone Marrow Transplantation/pathology
- CD40 Ligand/genetics
- CD40 Ligand/metabolism
- Cell Adhesion
- Cell Communication
- Dendritic Cells/immunology
- Female
- Graft vs Host Disease/etiology
- Graft vs Host Disease/immunology
- Graft vs Host Disease/pathology
- Interferon-gamma/deficiency
- Interferon-gamma/genetics
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
- Receptors, Antigen, T-Cell, gamma-delta/deficiency
- Receptors, Antigen, T-Cell, gamma-delta/genetics
- Receptors, Antigen, T-Cell, gamma-delta/metabolism
- T-Lymphocyte Subsets/immunology
- Transplantation, Homologous
- Tumor Necrosis Factor-alpha/deficiency
- Tumor Necrosis Factor-alpha/genetics
Collapse
Affiliation(s)
- Yoshinobu Maeda
- Department of Internal Medicine, 6310 CCGC, University of Michigan Cancer Center, 1500 East Medical Center Dr, Ann Arbor, MI 48109-0942, USA
| | | | | | | | | | | |
Collapse
|
7
|
Teshima T, Ferrara JLM. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 2002; 39:15-22. [PMID: 11799525 DOI: 10.1053/shem.2002.29246] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Graft-versus-host disease (GVHD) has been the primary limitation to the wider application of allogeneic bone marrow transplantation (BMT). GVHD occurs when donor T cells react to host antigens on antigen-presenting cells (APCs) and attack host tissues, with sequential activation of donor T cells and monocytes/macrophages. The net effects of dysregulated cytokine production in this complex system are the severe inflammatory manifestations that we recognize as clinical acute GVHD. Long-term outcomes are also adversely affected by chronic GVHD, which has distinctive clinical and pathologic manifestations that mimic autoimmune disease, although its exact pathogenesis remains ambiguous. The ultimate goal for preventing GVHD is the induction of specific tolerance to host antigens, thereby maintaining favorable aspects of donor immunity. Tolerance may be achieved by costimulatory blockade, deletion of activated cells, suppression by regulatory T cells, and immune deviation. This report will focus on these mechanisms as they relate to the pathophysiology of acute GVHD.
Collapse
Affiliation(s)
- Takanori Teshima
- Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, MI 48109-0942, USA
| | | |
Collapse
|
8
|
|